AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Buprigesic 0.3mg Injection

Prescription Icon
Prescription Required

Marketer

Neon Laboratories Ltd

Salt Composition

Buprenorphine (0.3mg)

Overview Buprigesic 0.3mg Injection

Buprenorphine 0.3mg injection is indicated for managing moderate to severe pain and alleviating opioid (morphine) addiction in individuals concurrently enrolled in a comprehensive treatment program incorporating medical, social, and psychological interventions. This medication is contraindicated for patients under 16 years of age. Administration of Buprenorphine 0.3mg injection should exclusively be performed by a qualified healthcare provider; self-administration is strictly prohibited. Dosage and treatment duration are individualized, contingent upon the specific indication and therapeutic response. Treatment should continue as directed by your physician. Frequently reported adverse reactions include asthenia, opioid withdrawal symptoms, apprehension, jitteriness, vertigo, cephalalgia, somnolence, bowel looseness, nausea, emesis, and abdominal discomfort. Persistent or worsening side effects necessitate immediate medical consultation. Your physician may offer strategies for mitigating these effects. Prior to initiating therapy, disclose any pre-existing respiratory illnesses, cardiovascular conditions, hepatic or renal dysfunction to your physician. Comprehensive medication reconciliation, including all concurrent medications, is crucial due to potential interactions. Pregnant or lactating individuals should consult their physician before commencing treatment. Long-term use may require regular monitoring of renal and hepatic function, along with relevant blood parameters.

Primary Ingredients of Buprigesic 0.3mg Injection

No text was provided to rewrite.

Uses of Buprigesic 0.3mg Injection

Morphine addiction; Management of significant to intense pain

Major Benefits of Buprigesic 0.3mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Buprigesic 0.3mg Injection:

  • Headache
  • Back pain
  • Drowsiness
  • Vomiting
  • Insomnia (difficulty in sleeping)
  • Drug withdrawal syndrome
  • Dizziness
  • Sleepiness
  • Abdominal pain
  • Weakness
  • Sweating
  • Constipation
  • Withdrawal syndrome
  • Infection
  • Vertigo
  • Inflammation of the nose
  • Chills
  • Flu-like symptoms
  • Nausea

How to use Buprigesic 0.3mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Buprigesic 0.3mg Injection works:

Belbuca 0.3mg injection, a partial opioid agonist, alleviates pain by modulating specific brain receptors, thereby altering pain perception and response.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Buprigesic 0.3mg Injection and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Buprigesic 0.3mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Buprigesic 0.3mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Administering Buprigesic 0.3mg Injection may induce drowsiness, blurred vision, and dizziness. Driving is inadvisable while experiencing these effects.

KidneyKidneyCAUTION

Administering Buprigesic 0.3mg Injection to individuals with significant renal impairment requires careful consideration. Dosage modification of Buprigesic 0.3mg Injection might be necessary. Physician consultation is recommended.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Buprigesic 0.3mg Injection, as dose modification may be necessary. Consult a physician before administration. Buprigesic 0.3mg Injection is contraindicated in patients exhibiting severe liver dysfunction.

What if you forget to take Buprigesic 0.3mg Injection :

NA

Facts to Know About Buprigesic 0.3mg Injection

LabelValue
Chemical Type Phenanthrene Derivatives
Developing Habits Affirmative.
Treatment Category Neuroscience of the Central Nervous System
Action Category Partial Opioid Agonists

FAQs on Buprigesic 0.3mg Injection

Buprigesic 0.3mg Injection treats severe pain unresponsive to other analgesics or where those are intolerable. It's unsuitable for mild, intermittent, or occasional pain, and isn't for "as needed" use. It also treats opioid use disorder.
Administer this medication by subcutaneous injection only; intravenous or intramuscular injection is strictly prohibited. Venous or muscular injection of Buprigesic 0.3mg Injection may cause skin and tissue damage, potentially leading to fatal blood clots.
Pain relief from intravenous administration typically begins within 10 to 30 minutes, reaching its peak effect within one hour.
Buprigesic 0.3mg Injection typically provides pain relief for about six hours, although individual experiences may differ.
A small lump may appear or be felt under your skin at the injection site. This is normal and should gradually decrease in size over several weeks. Avoid rubbing, massaging, or wearing tight clothing on the area. Contact your doctor if you have any concerns.
Seek immediate medical attention if you experience slow, gasping breaths, blue-tinged lips, or unresponsiveness.
This medication can cause drowsiness or dizziness, impairing your ability to drive or use machinery. Refrain from alcohol consumption, and seek medical advice if you have any concerns.
This medication can significantly lower your blood pressure, potentially causing dizziness upon standing, particularly if you're also taking anti-hypertensives. Consult your doctor about adjusting your dosage.
Prolonged use of this medication can lead to physical and psychological dependence, potentially resulting in withdrawal symptoms upon discontinuation.
Using Buprigesic 0.3mg Injection during pregnancy risks your baby developing a dependence that may lead to life-threatening withdrawal symptoms after birth. Such newborns may require several weeks of medical care.
Buprigesic 0.3mg Injection may transfer to breast milk, potentially causing drowsiness or breathing difficulties in infants. Consult your doctor thoroughly regarding the associated risks.
Buprigesic 0.3mg Injection, an opioid partial agonist-antagonist, provides pain relief. As a controlled substance with addictive potential, alternative pain management should be discussed with your doctor if addiction develops.
Yes. Buprigesic 0.3mg injections counteract the effects of opiates.
Buprigesic 0.3mg Injection is not associated with depression. Report any depressive symptoms to your doctor.
Buprigesic 0.3mg Injectio...
23
MRP 28
16% off